Pre-made Ivonescimab benchmark antibody ( Whole mAb, anti-VEGFA therapeutic antibody, Anti-VPF/VEGF/MVCD1 Antibody) for drug discovery and mechanism of action (MOA) research

Pre-Made Ivonescimab biosimilar, Whole mAb, Anti-VEGFA Antibody: Anti-VPF/VEGF/MVCD1 therapeutic antibody is a biosimilar expressed by mammalian cell line as a benchmark reference therapeutic antibody for biological drug disovery items including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.

Order information

* GeneMedi provides NON-PROFIT PRICE to support Academic research. Please click inquiry for product quotation. → Inquiry

Catalog No.	Package	Price(In USD)	Qty (Quantity)	Sum(In USD)
GMP-Bios-ab-674-1mg	1mg	3090
GMP-Bios-ab-674-10mg	10mg	Inquiry
GMP-Bios-ab-674-100mg	100mg	Inquiry
GMP-Bios-ab-674-xmg	＞100mg	Inquiry
			Shipping Cost:	760.00
			Total:

Description

Products Name (INN Index)	Pre-Made Ivonescimab biosimilar, Whole mAb, Anti-VEGFA Antibody: Anti-VPF/VEGF/MVCD1 therapeutic antibody
INN Name	Ivonescimab
Target	VEGFA
Format	scFv-IGHC
Derivation	Humanized
Species Reactivity	Human, Chimeric
CH1 Isotype	IgG1
VD LC	Kappa
Highest_Clin_Trial (Jan '20)	Phase-II
Est. Status	Active
100% SI Structure	1bj1:HL:KJ
99% SI Structure	None
95-98% SI Structure	6bft:AB:HL/1cz8:HL:YX
Year Proposed	2021
Year Recommended	na
Companies	Akeso Biopharma
Conditions Approved	na
Conditions Active	Non-small cell lung cancer;Solid tumours;Neoplasms;Gynecological Cancer
Conditions Discontinued	na
Development Tech	na